Column GROUP L P, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 22,631 shares at $0.71 ($16K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Open-market purchase of $16k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 16,791 | $12K | 76.7% |
| 2 | $0.62 | 5,840 | $4K | 23.3% |
| Total | $0.69 avg | 22,631 | $16K | 100% |
| Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |
| NGM | BUY | 2022-05-23 | $779K | — | Filing → |